Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 25 04:00PM ET
0.4620
Dollar change
+0.0019
Percentage change
0.41
%
Index- P/E- EPS (ttm)-1.41 Insider Own55.99% Shs Outstand11.00M Perf Week10.79%
Market Cap4.69M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.47M Perf Month70.29%
Income-14.95M PEG- EPS next Q- Inst Own0.98% Short Float2.06% Perf Quarter51.38%
Sales1.27M P/S3.70 EPS this Y- Inst Trans-37.55% Short Ratio0.03 Perf Half Y-7.64%
Book/sh-1.26 P/B- EPS next Y- ROA-58.28% Short Interest0.09M Perf Year-69.80%
Cash/sh0.03 P/C15.14 EPS next 5Y- ROE-115.17% 52W Range0.24 - 1.70 Perf YTD-4.35%
Dividend Est.- P/FCF- EPS past 5Y-8.00% ROI-119.32% 52W High-72.82% Beta0.30
Dividend TTM- Quick Ratio0.08 Sales past 5Y-4.02% Gross Margin16.21% 52W Low92.50% ATR (14)0.10
Dividend Ex-Date- Current Ratio0.08 EPS Y/Y TTM-7.67% Oper. Margin-429.19% RSI (14)51.24 Volatility13.89% 37.68%
Employees5 Debt/Eq1.39 Sales Y/Y TTM6.11% Profit Margin-1173.45% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq1.07 EPS Q/Q55.40% Payout- Rel Volume0.16 Prev Close0.46
Sales Surprise- EPS Surprise- Sales Q/Q6.22% Earnings- Avg Volume2.84M Price0.46
SMA20-5.99% SMA5025.50% SMA200-7.22% Trades Volume442,227 Change0.41%
Jun-21-24 07:30AM
Jun-20-24 08:30AM
Jun-04-24 11:00AM
08:55AM
07:28AM
02:53PM Loading…
Jun-03-24 02:53PM
May-24-24 05:00PM
May-21-24 08:30AM
Apr-22-24 09:00AM
Apr-16-24 09:52AM
Mar-28-24 09:00AM
Dec-18-23 09:00AM
Oct-18-23 09:00AM
Oct-04-23 09:00AM
Sep-13-23 09:15AM
08:00AM Loading…
Sep-05-23 08:00AM
Aug-30-23 10:45AM
09:00AM
Aug-21-23 09:00AM
Jul-24-23 09:00AM
Jul-19-23 09:00AM
Jul-10-23 09:00AM
Apr-27-23 09:00AM
Apr-17-23 09:00AM
Apr-11-23 09:00AM
Mar-03-23 09:00AM
Feb-13-23 09:00AM
Jan-17-23 09:00AM
Jan-11-23 09:00AM
Jan-03-23 09:00AM
09:00AM Loading…
Dec-14-22 09:00AM
Dec-12-22 09:00AM
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties. The Medical Related Consulting segment relates to labor and related benefits, travel expenses, and related to consulting services. The company was founded on July 28, 2014 and is headquartered in Freehold, NJ.